Spero Biopharma Company
Spero Biopharma is developing Ladostigil an innovative treatment for Mild Cognitive Impairment.
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2019-06-01
Register and Claim Ownership